We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+29.5%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$3.32B
AUM Growth
+$1.18B
Cap. Flow
+$615M
Cap. Flow %
18.49%
Top 10 Hldgs %
78.29%
Holding
632
New
99
Increased
142
Reduced
57
Closed
309

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$375M
2
BABA icon
Alibaba
BABA
+$289M
3
TSM icon
TSMC
TSM
+$200M
4
BLK icon
Blackrock
BLK
+$182M
5
CSCO icon
Cisco
CSCO
+$116M

Sector Composition

Rank Sector Weight
1 Technology 27.64%
2 Financials 23.55%
3 Consumer Discretionary 16%
4 Healthcare 3.24%
5 Industrials 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TR icon
251
Tootsie Roll Industries
TR
$3.02B
$22K ﹤0.01%
+777
New +$23.1K
NUAN
252
DELISTED
Nuance Communications, Inc.
NUAN
$22K ﹤0.01%
853
-557
-40% -$11.6K
GLOG
253
DELISTED
GASLOG LTD
GLOG
$22K ﹤0.01%
8,000
HZNP
254
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$22K ﹤0.01%
401
+15
+4% +$642
AMED
255
DELISTED
Amedisys
AMED
$21K ﹤0.01%
108
+25
+30% +$4.66K
CDNA icon
256
CareDx
CDNA
$2.45B
$21K ﹤0.01%
+599
New +$17K
CTSO icon
257
Cytosorbents Corp
CTSO
$22.8M
$21K ﹤0.01%
+2,098
New +$19.3K
OSUR icon
258
OraSure Technologies
OSUR
$277M
$21K ﹤0.01%
+1,767
New +$23K
PCRX icon
259
Pacira BioSciences
PCRX
$924M
$21K ﹤0.01%
+407
New +$17K
ANSS
260
DELISTED
Ansys
ANSS
$20K ﹤0.01%
69
-1,995
-97% -$531K
IRWD icon
261
Ironwood Pharmaceuticals
IRWD
$674M
$20K ﹤0.01%
1,950
+820
+73% +$8.39K
CHE icon
262
Chemed
CHE
$7.02B
$19K ﹤0.01%
42
+10
+31% +$4.46K
PEN icon
263
Penumbra
PEN
$12.9B
$19K ﹤0.01%
109
+30
+38% +$5.21K
RGEN icon
264
Repligen
RGEN
$9.45B
$19K ﹤0.01%
+157
New +$18.5K
ROK icon
265
Rockwell Automation
ROK
$49.5B
$19K ﹤0.01%
88
+20
+29% +$3.87K
NAGE
266
Niagen Bioscience
NAGE
$241M
$19K ﹤0.01%
+4,177
New +$18.7K
NVRO
267
DELISTED
NEVRO CORP.
NVRO
$19K ﹤0.01%
157
-70
-31% -$8.3K
DVA icon
268
DaVita
DVA
$11.4B
$18K ﹤0.01%
232
-34
-13% -$2.65K
EBS icon
269
Emergent Biosolutions
EBS
$230M
$18K ﹤0.01%
+225
New +$16.8K
ICUI icon
270
ICU Medical
ICUI
$4.58B
$18K ﹤0.01%
+99
New +$19.7K
CTLT
271
DELISTED
CATALENT, INC.
CTLT
$18K ﹤0.01%
+248
New +$16.8K
GNOG
272
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
$18K ﹤0.01%
+1,100
New +$11.2K
LFVN icon
273
LifeVantage
LFVN
$81.9M
$17K ﹤0.01%
1,257
+203
+19% +$2.81K
ETSY icon
274
Etsy
ETSY
$7.4B
$16K ﹤0.01%
155
+145
+1,450% +$10.7K
PDD icon
275
Pinduoduo
PDD
$120B
$16K ﹤0.01%
188
+57
+44% +$3.43K

Similar funds

Altshuler Shaham's Q2 2020 Portfolio in Review

As of Q2 2020, Altshuler Shaham held 632 positions worth $3.32B, up 55% from $2.15B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Altshuler Shaham deployed $615M of net new capital in Q2 2020, opening 99 new positions and adding to 142 existing holdings. Its largest new stake was KraneShares CSI China Internet ETF: 205,053 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was State Street Financial Select Sector SPDR ETF, an estimated $327M trimmed.

  • Altshuler Shaham's largest Q2 2020 buy was KraneShares CSI China Internet ETF: 205,053 shares worth $12.7M.
  • Altshuler Shaham added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $375M increase.
  • Altshuler Shaham's biggest Q2 2020 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $327M.
  • Altshuler Shaham fully exited Royal Caribbean in Q2 2020, selling an estimated $866K.
  • Altshuler Shaham's ten largest holdings make up 78% of its $3.32B portfolio in Q2 2020.
  • Altshuler Shaham opened 99 new positions and closed 309 in Q2 2020.
  • Altshuler Shaham's portfolio value rose 55% quarter-over-quarter to $3.32B.

Based on Altshuler Shaham's 13F filing for Q2 2020, filed 13 Aug 2020.